Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2005-06-08 FAHIM RAAFAT E F Sr. VP Tech. & Prod. Purchase +2,000 $12.15 $24K 5,630.68
2005-05-31 SMITH MARK L Sr. VP Fin., CFO, CAO & Treas. Other acquisition +1,228.44 $10.58 $13K 19,908.23
2005-05-31 RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. Other acquisition +921.33 $10.58 $10K 1,876.35
2005-05-31 MCLAIN THOMAS H Chairman, CEO & President Other acquisition +1,228.44 $10.58 $13K 48,776.25
2005-05-31 FAHIM RAAFAT E F Sr. VP Tech. & Prod. Other acquisition +1,228.44 $10.58 $13K 6,859.12
2005-05-27 COX GEOFFREY F Director Exercise or conversion +7,500 $3.25 $24K 20,479
2005-05-27 COX GEOFFREY F Director Shares withheld for taxes −1,958 $12.45 $24K 18,521
2005-05-27 COX GEOFFREY F Director Exercise or conversion · Stock Option (right to buy) −7,500 0
2005-05-26 HARVEY RICHARD A JR Director Exercise or conversion +4,500 $4.88 $22K 23,496
2005-05-26 HARVEY RICHARD A JR Director Exercise or conversion · Stock Option (right to buy) −4,500 0

Page 42 of 42 · 830 trades